Pharmaceutical

Sir John Bell, one of Britain's leading life sciences leaders, warned of an imminent exodus of pharmaceutical companies from London, calling the City "a bad place to raise funds". Sir John, a veteran of the industry known for his crucial…

Novo Nordisk's attempts to alleviate global shortages of the "wonder drug", which it claims to be a weight-loss miracle, have led them to a businesspark on the outskirts Dublin. Last year, the Danish group overtook LVMH (the French…

Novo Nordisk's shares reached a new record high following the Danish company's report of soaring sales for its obesity and diabetic drugs Wegovy, and Ozempic. This pushed its market value over $500bn. It also cemented its position as…

Haleon sold ChapStick for more than $500m as it sought to reduce its debts while also boosting its stock price. The FTSE-100 company has agreed that it will sell its lip balms to Suave Brands for approximately $430 million cash plus a…

Syntara's $10M capital raise is propelling its drug development strategy into a new era. In this exclusive interview, CEO Gary Phillips unveils the transformative steps taken by Syntara Ltd, from its rebranding efforts to the strategic…

Boots, the US-owned high street pharmacy chain, is considering a £7bn UK IPO. This could give London's struggling stock market a needed boost. Walgreens Boots Alliance, which abandoned its plan to sell Boots two years ago, is believed to…

Novo Nordisk wants to help more people get Wegovy jabs, including those who are currently unable to access them. Novo Nordisk, a maker of obesity drugs, said that it would offer countries the option to "buy now and pay later" for its…

The landscape of vaccine technology is witnessing a revolutionary change with the introduction of TNX-1800, a next-generation COVID-19 vaccine developed by Tonix Pharmaceuticals. Led by CEO Dr. Seth Lederman, the company has made…

Boots reduces investment. It will close stores. It may have to face another complex corporate restructuring. Boots should have a great decade, as the NHS is in a constant state of crisis. People are taking more responsibility for…

Merck's chief research officer has called for the UK government make the country more welcoming of pharma companies. This is ahead of next week, when the US-based company will break ground in London on a £1bn Research Centre. Dean Li,…

Mixed reactions have been received in Denmark by the sudden surge of interest in Wegovy What happens when you find a weight-loss drug that is a "miracle", and may even be the best-selling medicine of all time. Of course, throw…

Environmentalists, as well as a major European investor, are putting pressure on pharmaceuticals companies to find alternatives to using the blood of horseshoe crayfish to test medical devices and vaccines. Blood is used in millions of…

The Supreme Court has put Purdue Pharma’s bankruptcy settlement of $6bn on hold. This would have shielded members of the Sackler Family who own the company against future lawsuits related to the US opioid epidemic. The court granted a…

A booming weight-loss drug market has investors scrambling for a piece of the action After Copenhagen-headquartered Novo Nordisk published trial data this week suggesting its weight-loss jab Wegovy cut the risk of heart attacks…

AstraZeneca’s second quarter of 2023 has been successful, with eight different medicines generating over US$1 billion in sales. The company has also seen positive results in eight separate Phase III oncology trials, with more data expected…

Pharmaceutical giants are pouring tens of millions of pounds into struggling NHS services - including paying the salaries of medical staff and funding the redesign of patient treatment - as they seek to boost drug sales in the UK. Drug…

Dechra Pharmaceuticals warned that its earnings would be lower than expected, as it negotiates with a Swedish firm for a £4.6billion takeover. The company informed investors that its profits would be affected by American wholesalers'…